Close

News

Cryoport Acquires Temperature-Controlled Logistics Provider in Australia

Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced it has acquired Critical Transport Solutions Australia Pty Ltd , a market leader in providing premium healthcare logistics management services, specializing in time-...

Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine

Sanofi announced an investment of more than €600 million in a new vaccine manufacturing facility at its existing site in Toronto, Canada. The investment in a new facility will provide additional antigen and filling capacity for Sanofi’s Fluzone® High-Dose...

Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover

Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the initiation of crossover arms in two ongoing clinical trials of NVX-CoV2373, the company's COVID-19 vaccine candidate. Crossover ensures the administration of active vaccine to all...

SIRO Clinpharm partners with ACROSS Global Alliance; aims to bridge the gap in the pharmaceutical service provider market

SIRO Clinpharm, a Clinical Research Organisation in India announced that they have become a partner of ACROSS Global Alliance (ACROSS) and will help represent India in working towards the common goals and objectives of ACROSS in bridging a gap...

Anixa Biosciences, OntoChem ink pact to proceed to next stage of development of potential anti-viral therapy for Covid-19

Anixa Biosciences, Inc., a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced that based on Proof of Concept (POC) animal study results, it will progress to the next stage of development of its...

Crystec launch a new R&D centre in Haimen, Jiangsu province, China

Crystec are pleased to announce the opening of a new subsidiary, Nantong Crystec Pharmaceutical R&D Co. Ltd., and research facility, located at Haimen Science and Technology Park in Haimen City, Jiangsu Province, China. Crystec’s new R&D centre has been established...

Iconovo and ISR develop new covid-19 inhalation vaccine

Inhalation device company Iconovo, which offers complete inhalation products, signed an agreement with immunotherapy company ISR Immune System Regulation. The agreement concerns the development of an inhalation vaccine against Covid-19 in Iconovo’s disposable inhaler ICOone. The parties see significant...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »